Login

Endo International plc 3 SEC Filings

Filed On Filing
24 Feb 2022 Form 3: Tursi James Patrick, Executive VP, Global R&D

Holds 280,373 shares of 2015 Stock Incentive Plan Restricted Stock Units (RSU)

09 Aug 2021 Form 3: Raciti Frank B., VP, Controller and CAO

Holds 6,152 shares of Ordinary Shares

17 Feb 2021 Form 3: Chao Jennifer M, Director

Holds 0 shares of No securities beneficially owned

12 Nov 2020 Form 3: Apostol George, EVP, Head of Global R&D

Holds 45,811 shares of 2015 Stock Incentive Plan Restricted Stock Units (RSU)

29 Oct 2020 Form 3: Endo International plc, See footnotes (1)(2)(3)(4) · BIOSPECIFICS TECHNOLOGIES CORP

Holds 0 shares of Common Stock, $0.001 par value

29 Jul 2020 Form 3: Smith Mary Christine, Director

Holds 0 shares of No securities beneficially owned

06 Mar 2020 Form 3: Bradley Mark T., EVP, Chief Financial Officer

Holds 11,887 shares of Ordinary Shares

28 Feb 2020 Form 3: Barberio Mark G, Director

Holds 0 shares of No securities beneficially owned

03 Oct 2019 Form 3: Boyle Jack D., SVP, Interim Controller

Holds 16,239 shares of Ordinary Shares

09 Aug 2019 Form 3: Garella Rahul, EVP, Intl Pharmaceuticals

Holds 24,116 shares of Ordinary Shares

09 Aug 2019 Form 3: Ciarico Domenico, EVP & Chief Commercial Officer

Holds 10,744 shares of Ordinary Shares

03 Apr 2018 Form 3: Nichol Carrie Ann, VP, Controller & CAO

Holds 3,286 shares of Ordinary Shares

06 Mar 2018 Form 3: Barry Patrick A, EVP & Chief Commercial Officer

Holds 3,180 shares of Ordinary Shares

13 Nov 2017 Form 3: Mansukani Sharad, Director

Holds 23,793 shares of Ordinary Shares

22 Nov 2016 Form 3: Coleman Blaise, SVP Glob Finance & Interim CFO

Holds 3,153 shares of Ordinary Shares

08 Nov 2016 Form 3: Pera Antonio R, President, Par Pharmaceutical

Holds 19,022 shares of Ordinary Shares

08 Nov 2016 Form 3: Coughlin Terrance J, EVP & Chief Operating Officer

Holds 119,837 shares of Ordinary Shares

18 Aug 2016 Form 3: Ciaffoni Joseph, President, U.S. Branded Pharma

Holds 0 shares of No securities beneficially owned

09 May 2016 Form 3: Ingram Douglas S, Director

Holds 0 shares of No securities beneficially owned

05 May 2016 Form 3: Sisitsky Todd Benjamin, Director

Holds 0 shares of No securities beneficially owned

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support